glp-1 research How RWD is transforming GLP-1 Prescriptions Quadruple Since 2021

2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)

The anabolic effects of GIP may play a physiologically permissive role for adipose tissue synthesis, and GIP antagonist antibodies have been developed as pharmacological agents for obesity treatment (68, 74) ( Figure 1 Section E)

Additionally, both treatments are minimally invasive with quick recovery times, allowing for a prompt return to daily activities without significant downtime

L-CARNITINA, QUEMADOR DE GRASA Y ALIMENTO PARA TUS MSCULOS La L-Carnitina es considerada uno de los ingredientes nutricionales ms efectivos tanto para programas de reduccin de peso, como para deportistas con la necesidad de recuperarse eficazmente tras el ejercicio

* Correspondence: Xin Xu, [email protected] ORCID: Xin Xu, orcid.org/0000-0002-7216-3787 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers